| Literature DB >> 15225857 |
Bo Shopsin1, Xilin Zhao, Barry N Kreiswirth, Glenn S Tillotson, Karl Drlica.
Abstract
The use of quinolones in the treatment of non-serious community-acquired methicillin-resistant Staphylococcus aureus is discussed. The new C8-modified quinolones may be suitable for such treatment but controlled trials should be carried out to ensure that the pharmacokinetics are such that there is little risk of resistance developing.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15225857 DOI： 10.1016/j.ijantimicag.2004.03.009
Source DB: PubMed Journal: Int J Antimicrob Agents ISSN： 0924-8579 Impact factor: 5.283